Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

ABBADESSA, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.216
EU - Europa 2.422
AS - Asia 1.813
SA - Sud America 280
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 7.813
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.147
SG - Singapore 640
DE - Germania 553
RU - Federazione Russa 531
CN - Cina 485
IT - Italia 319
FI - Finlandia 260
BR - Brasile 222
UA - Ucraina 221
HK - Hong Kong 182
VN - Vietnam 163
SE - Svezia 118
GB - Regno Unito 104
PL - Polonia 90
JP - Giappone 82
IE - Irlanda 72
FR - Francia 58
KR - Corea 55
IN - India 52
CA - Canada 38
CI - Costa d'Avorio 26
BD - Bangladesh 25
ES - Italia 19
IQ - Iraq 18
TR - Turchia 18
BE - Belgio 17
IR - Iran 16
MX - Messico 15
NL - Olanda 13
AR - Argentina 12
AT - Austria 12
ID - Indonesia 12
MA - Marocco 12
ZA - Sudafrica 12
VE - Venezuela 11
CO - Colombia 10
PK - Pakistan 9
RO - Romania 8
EG - Egitto 7
EC - Ecuador 6
KE - Kenya 6
MY - Malesia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CL - Cile 5
PH - Filippine 5
PY - Paraguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
GR - Grecia 4
PE - Perù 4
TN - Tunisia 4
AL - Albania 3
CR - Costa Rica 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
TH - Thailandia 3
UY - Uruguay 3
AO - Angola 2
AU - Australia 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
KH - Cambogia 2
LT - Lituania 2
MD - Moldavia 2
NG - Nigeria 2
QA - Qatar 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AE - Emirati Arabi Uniti 1
BW - Botswana 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 7.813
Salva come PNG Salva come JPEG
Città #
Ashburn 452
Singapore 426
Fairfield 229
Chandler 207
San Jose 190
Hong Kong 173
Woodbridge 145
Ann Arbor 132
Wilmington 128
Jacksonville 111
Houston 96
Seattle 95
Moscow 87
Tokyo 81
Zgierz 76
Cambridge 73
Frankfurt am Main 73
Boardman 72
Dublin 72
Beijing 66
Santa Clara 63
Medford 60
Nanjing 60
Los Angeles 57
Des Moines 56
Ho Chi Minh City 50
Hefei 49
The Dalles 43
Palermo 42
New York 40
Hanoi 39
Chicago 38
Princeton 38
Dearborn 35
Dallas 34
Lauterbourg 33
Altamura 31
Helsinki 29
Abidjan 26
Council Bluffs 25
Tulsa 25
San Mateo 24
Buffalo 23
Shenyang 23
Lawrence 22
Milan 22
São Paulo 20
Orem 19
Jinan 18
Tianjin 17
Brussels 16
Ludwigshafen am Rhein 16
Nanchang 16
Da Nang 14
London 14
Seongnam 13
Hebei 12
Jiaxing 12
San Diego 12
Atlanta 11
Changsha 11
Seoul 11
Warsaw 11
Zhengzhou 11
City of London 10
Denver 10
Falls Church 10
Poplar 10
Tehran 10
Washington 10
Columbus 9
Haiphong 9
Kumar 9
Montreal 9
Ningbo 9
Amsterdam 8
Chennai 8
Guangzhou 8
Rome 8
Saint Petersburg 8
Baghdad 7
Mumbai 7
Phoenix 7
Rio de Janeiro 7
Toronto 7
Verona 7
Auburn Hills 6
Brooklyn 6
Cardiff 6
Erice 6
San Paolo di Civitate 6
Shanghai 6
Stockholm 6
Curitiba 5
Haikou 5
Johannesburg 5
Mexico City 5
Nairobi 5
Napoli 5
Salvador 5
Totale 4.489
Salva come PNG Salva come JPEG
Nome #
Heterocyclic and Phenyl Double-Bond-Locked Combretastatin Analogues Possessing Potent Apoptosis-inducing activity in HL60 and in MDR Cell lines 358
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. 345
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 319
Hepatitis B virus reactivation and alemtuzumab therapy 315
Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells 303
Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cells 283
Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma. 251
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. 249
Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma 240
Pre-empitive treatment with ciclofovir for cytomegalovirus antigenemia in autologous bone marrow recipient and CLL patients on therapy with alentuzumab 234
Hepatitis B virus reactivation and alemtuzumab therapy 226
The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study 225
Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis. 219
Effects of Propolis in cancer cells 212
Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients 206
Response-based chemotherapy and involved field radiation for intermediate stage Hodgkin disease. A GISL/NHLSG trial. 206
Screening sierologico per l'infantum in soggetti HIV+ in area endemica Sicilia occidentale 202
Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly. 199
Screening sierologico per Leishmania infantum su donatori di sangue e HIV+ asintomatici residenti in area endemica [Serological screening for Leishmania infantum in asymptomatic blood donors and HIV+ patients living in an endemic area] 196
ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS 195
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. 191
“Weekly regimen of cisplatin, epirubicin, 5-Fluorouracil and folinic acid with G-CSF is active in advanced gastroesophageal (GE) and gastric (G) cancer: a phase II study” 188
Presenting features and outcome of Splenic Marginal Zone Lymphoma with or without villous lymphocytes. A retrospective analysis in a Series of 145 Patients 188
PNEUMOCYSTIS JIROVECI PNEUMONIA IN HEMATOLOGICAL PATIENTS: A SINGLE INSTITUTION EXPERIENCE 177
BENDAMUSTINE (B) IN COMBINATION WITH RITUXIMAB (R) FOR PATIENTS WITH RELAPSED/RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): AN ITALIAN MULTICENTRE RETROSPECTIVE STUDY 177
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA. FINAL RESULTS OF A MULTICENTER STUDY 176
Apoptosis in infectious diseases 168
ABSOLUTE LYMPHOCYTE COUNT AS PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA 166
CD200 ANTIGEN IN B-CELL DERIVED NEOPLASMS: EXPRESSION AND CLINICAL IMPACT IN 77 CONSECUTIVE PATIENTS OF A SINGLE ISTITUTION 158
Presenting features and prognostic factors in Splenic Marginal Zone Lymphoma. A study on 145 patients. 158
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA 155
Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura -haemolytic uraemic syndrome. 152
CANCER AS A PREDICTOR FOR INCREASED PERIPROCEDURAL BLEEDING DURING SURGERY OR PLATELET-INDUCED CHEMOTHERAPY IN CHRONICALLY ANTICOAGULATED PATIENTS 152
Successful treatment of acquired haemophilia with FEIBA and Retuximab 149
INFEZIONE DA HIV E IMMIGRATI NEGLI ULTIMI CINQUE ANNI DI ATTIVITA' DEL NOSTRO CENTRO 145
3 137
PREDICTORS OF RESIDUAL VEIN THROMBOSIS AFTER CANCER-RELATED DEEP VEIN THROMBOSIS OF THE LOWER LIMBS 136
Monocyte and lymphocyte apoptosis resistance in acute and chronic brucellosis and its possible implications in clinical management 121
Totale 7.877
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022497 62 101 3 10 19 8 21 15 64 91 25 78
2022/2023589 52 101 9 63 69 105 39 49 68 4 22 8
2023/2024281 5 50 24 36 28 62 22 20 0 7 1 26
2024/2025787 30 30 31 70 39 30 88 62 51 90 93 173
2025/20263.056 215 94 145 264 301 428 360 295 207 525 95 127
2026/202750 50 0 0 0 0 0 0 0 0 0 0 0
Totale 7.877